✦ LIBER ✦

Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway

✍ Scribed by Wataru Ichikawa

Publisher: Springer
Year: 2006
Tongue: English
Weight: 376 KB
Volume: 9
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-006-0373-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of clinical outcome of S-1-ba

Prediction of clinical outcome of S-1-based chemotherapy for gastric cancer patients

✍ Wataru Ichikawa; Yasutsuna Sasaki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 296 KB

Predicting clinical outcome of 5-fluorou

Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?

✍ Barry Iacopetta; Kazuyuki Kawakami; Toshiaki Watanabe 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB

Anemia is the strongest prognostic facto

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer

✍ Se Hoon Park; Jeeyun Lee; Se Hoon Lee; Joon Oh Park; Kihyun Kim; Won Seog Kim; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 199 KB

Single nucleotide polymorphism in the 5′

Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients

✍ Eugenio Marcuello; Albert Altés; Elisabeth del Rio; Angeles César; Anna Menoyo; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

## Abstract Thymidylate synthase (TS) is the primary target of 5‐fluorouracil (5‐FU). A VNTR polymorphism in the TS promoter region is associated with the efficacy of 5‐FU‐based chemotherapy in colorectal cancer. A common G>C SNP at the 12th nucleotide of the second repeat in the TS\*3 alleles has

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views